Basic Neuroscience and Scanning

Handbook of Eating Disorders: Second Edition

Volumn , Issue , 2005, Pages 89-101

  de Zwaan, Martina ^a  

^a Department of General Psychiatry ^*  (Austria)

Author keywords

Dopamine metabolism; Functional imaging; Neuroimaging

Indexed keywords

EID: 84909364022     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470013443.ch5     Document Type: Chapter

References (72)

1. Andreason, P.J., Altemus, M., Zametkin, A.J., King, A.C., Lucinio, J. & Cohen, R.M. (1992) Regional cerebral glucose metabolism in bulimia nervosa. American Journal of Psychiatry, 149, 1506-1513.
2. Attia, E., Haiman, C., Walsh, B.T. & Flater, S.R. (1998) Does fluoxetine augment the inpatient treatment of anorexia nervosa? American Journal of Psychiatry, 155, 548-551.
3. Blundell, J.E. (1991) Pharmacological approaches to appetite suppression. Trends in Pharmacological Science, 12, 147-157.
4. Brewerton,T.D.& Jimerson, D.C. (1996) Studies of serotonin function in anorexia nervosa. Psychiatry Research, 62, 31-42.
5. Brewerton, T.D., Mueller, E.A., Lesem, M.D., Brandt, H.A., Quearry, B., George, D.T., Murphy, D.L. & Jimerson, D.C. (1992) Neuroendocrine responses to m-Chlorophenylpiperazine and l-Tryptophan in bulimia. Archives of General Psychiatry, 49, 852-861.
6. Carrasco, J.L., Diaz-Marsa, M., Hollander, E., Cesar, J. & Saiz-Ruiz, J. (2000) Decreased platelet monoamine oxidase activity in female bulimia nervosa. European Neuropsychopharmacology, 10, 113-117.
7. Delvenne, V., Goldman, S., Biver, F., De Maertalaer, V.,Wikler, D., Damhaut, P. & Lotstra, F. (1997a) Brain hypometabolism of glucose in low-weight depressed patients and in anorectic patients: a consequence of starvation? Journal of Affective Disorders, 44, 69-77.
8. Delvenne, V., Goldman, S., Simon, Y., De Maertalaer, V.&Lotstra, F. (1997b) Brain hypometabolism of glucose in bulimia nervosa. International Journal of Eating Disorders, 21, 313-320.
9. Delvenne,V., Goldman, S., Simon,Y.,De Maertalaer,V.&Lotstra, F. (1999) Brain glucose metabolism in eating disorders as assessed by positron emission tomography. International Journal of Eating Disorders, 25, 29-37.
10. Delvenne, V., Lotstra, F., Goldman, S., Biver, F., De Maertalaer, V., Appelboom-Fondu, J., Schoutens, A., Bidaut, L.M., Luxen, A.&Mendlewicz, J. (1995) Brain hypometabolism of glucose in anorexia nervosa: a PET scan study. Biological Psychiatry, 37, 161-169.
11. Doraiswamy, P.M., Krishan, K.R., Figiel, G.S., Husain, M.M., Boyko, O.B., Rockwell, W.J.K. & Ellinwood, E.H. (1990) A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. Biological Psychiatry, 28, 110-116.
12. Ellison, Z., Foong, J., Howard, R., Bullmore, E., Williams, S. & Treasure, J. (1998) Functional anatomy of calorie fear in anorexia nervosa. Lancet, 352, 1192 (Research letter).
13. Fluoxetin Bulimia Nervosa Collaborative Study Group (1992) Fluoxetine in the treatment of bulimia nervosa: A multicenter placebo-controlled double-blind trial. Archives of General Psychiatry, 49, 139-147.
14. Frank, G.K., Kaye, W.H., Greer, P., Meltzer, C.C. & Price, J.C. (2000) Regional cerebral blood flow after recovery from bulimia nervosa. Psychiatry Research, 20, 31-39.
15. Frank, G.K., Kaye, W.H., Meltzer, C.C., Price, J.C., Greer, P., McConaha, C. & Skovira, K. (2002) Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biological Psychiatry, 52, 896-906.
16. Frank, G.K., Kaye, W.H., Weltzin, T.E., Perel, J., Moss, H., McConaha, C. & Pollice, C. (2001) Altered response to meta-chlorophenylpiperazine in anorexia nervosa: Support for a persistent alteration of serotonin activity after short-term weight restoration. International Journal of Eating Disorders, 30, 57-68.
17. Goldbloom, D.S., Hicks, L. & Garfinkel, P.E. (1990) Platelet serotonin uptake in bulimia nervosa. Biological Psychiatry, 28, 644-647.
18. Goldbloom, D.S., Garfinkel, P.E., Katz, R.&Brown, G. (1990) The hormonal response to intravenous 5-hydroxytryptophan in bulimia nervosa. Psychosomatic Medicine, 52, 225-226.
19. Golden, N.H., Ashtari, M.,Kohn, M.R., Patel, M., Jacobson, M.S., Fletcher,A.&Shenker, I.R. (1996) Reversibility of cerebral ventricular enlargment in anorexia nervosa, demonstrated by quantitative magnetic resonance imaging. Journal of Pediatrics, 128, 296-301.
20. Goldstein, D.J.,Wilson, M.G., Thompson,V.L., Potvin, J.H., Rampey, A.H.&The Fluoxetine Bulimia Nervosa Research Group (1995) Long-term fluoxetine treatment of bulimia nervosa. British Journal of Psychiatry, 166, 660-666.
21. Gordon, C.M., Dougherty, D.D., Rauch, S.L., Emans, S.J., Grace, E., Lamm, R., Alpert, N.M., Majzoub, J.A. & Fischman, A.J. (2000) Neuroanatomy of human appetitive function: a positron emission tomography investigation. International Journal of Eating Disorders, 27, 163-171.
22. Gordon, I., Lask, B., Bryant-Waugh, R., Christie, D. & Timimi, S. (1997) Childhood-onset anorexia nervosa: towards identifying a biological substrate. International Journal of Eating Disorders, 22, 159-165.
23. Hadigan, C.M., Walsh, B.T., Buttinger, C. & Hollander, E. (1995) Behavioural and neuroendocrine responses to meta-CPP in anorexia nervosa. Biological Psychiatry, 37, 504-511.
24. Halmi, K.A., Eckert, E., LaDu, T.J. & Cohen, J. (1986) Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Archives of General Psychiatry, 43, 177-181.
25. Herholz, K., Krieg, J.C., Emrich, H.M., Pawlik, G., Bell, C., Pirke, K.M., Pahl, J.J., Wagner, R., Wienhard, K., Ploog, D. & Heiss,W.D. (1987) Regional cerebral glucose metabolism in anorexia nervosa measured by positron emission tomography. Biological Psychiatry, 22, 43-51.
26. Husain, M.M., Black, K.J., Doraiswamy, P.M., Shah, S.A., Rockwell, W.J.K., Ellinwood, E.H. & Krishan, K.R. (1992) Subcortical brain anatomy in anorexia and bulimia. Biological Psychiatry, 31, 735-738.
27. Jimerson, D.C., Lesem, M.D., Kaye, W.H. & Brewerton, T.D. (1992) Low serotonin and dopamine metabolite concentration in cerebrospinal fluid from bulimic patients with frequent binge episodes. Archives of General Psychiatry, 49, 132-138.
28. Jimerson, D.C., Wolfe, B.E., Metzger, E.D., Finkelstein, D.M., Cooper, T.B. & Levine, J.M. (1997) Decreased serotonin function in bulimia nervosa. Archives of General Psychiatry, 54, 529-534.
29. Katzman, D.K., Lambe, E.K., Mikulis, D.J., Ridgley, J.N., Goldbloom, D.S. & Zipursky, R.B. (1996) Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. Journal of Pediatrics, 129, 794-803.
30. Kaye, W.H., Ballenger, J.C., Lydiard, R.B., Stuart, G.W., Laraia, M.T., O'Neil, P., Fossey, M.D., Stevens, V., Lesser, S.C. & Hsu, G. (1990) CSF monoamine levels in normal weight bulimia: evidence for abnormal noradrenergic activity. American Journal of Psychiatry, 147, 225-229.
31. Kaye, W.H., Ebert, M.H., Raleigh, M. & Lake, R. (1984) Abnormalities in CNS monoamine metabolism in anorexia nervosa. Archives of General Psychiatry, 41, 350-355.
32. Kaye, W.H., Frank, G.K.W. & McConaha, C. (1999) Altered dopamine activity after recovery from restricting-type anorexia nervosa. Neuropsychopharmacology, 21, 503-506.
33. Kaye, W.H., Frank, G.K., Meltzer, C.C., Price, J.C., McConaha, C.W., Crossan, P.J., Klump, K.L. & Rhodes, L. (2001) Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. American Journal of Psychiatry, 158, 1152-1155.
34. Kaye, W.H., Gendall, K.A., Fernstrom, M.H., Fernstrom, J.D., McConaha, C.W. & Weltzin, T.E. (2000) Effects of acute tryptophan depletion on mood in bulimia nervosa. Biological Psychiatry, 47, 151-157.
35. Kaye, W.H., Greeno, C.G., Moss, H., Fernstrom, J., Fernstrom, M., Lilenfeld, L.R., Weltzin, T.E. & Mann, J.J. (1998) Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Archives of General Psychiatry, 55, 927-935.
36. Kaye, W.H., Gwirtsman, H.E., Brewerton, T.D., George, D.T. & Wurtman, R.J. (1988b) Bingeing behavior and plasma amino acids: a possible involvement of brain serotonin in bulimia nervosa. Psychiatry Research, 23, 31-43.
37. Kaye, W.H., Gwirtsman, H.E., George, D.T., Jimerson, D.C. & Ebert, M.H. (1988a) CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalise after weight restoration. Biological Psychiatry, 23, 102-105.
38. Kaye, W.H., Gwirtsman, H.E., George, D.T. & Ebert, M.H. (1991) Altered serotonin activity in anorexia nervosa after long-term weight restoration: does elevated cerebrospinal 5- hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Archives of General Psychiatry, 48, 556-562.
39. Kaye,W.H., Nagata, T.,Weltzin, T.E., Hsu, L.K., Sokol, M.S., McConaha, C., Plotnikov, K.H.,Weise, J. & Deep, D. (2001) Double-blind placebo-controlled administration of fluoxetine in restrictingand purging-type anorexia nervosa. Biological Psychiatry, 49, 644-652.
40. Krieg, J.C., Backmund, H. & Pirke, K.M. (1986) Endocrine, metabolic and brain morphological abnormalities in patients with eating disorders. International Journal of Eating Disorders, 5, 999-1005.
41. Krieg, J.C., Backmund, H. & Pirke, K.M. (1987) Cranial computed tomography findings in bulimia. Acta Psychiatrica Scandinavica, 75, 144-149.
42. Krieg, J.C., Lauer, C., Leisinger, G., Pahl, J., Wolfgang, S., Pirke, K.M. & Moser, E.A. (1989) Brain morphology and regional cerebral blood flow in anorexia nervosa. Biological Psychiatry, 25, 1041-1048.
43. Lakenau, H., Swigar, M.E., Bhimani, S., Luchins, D. & Quilan, D.M. (1985). Cranial CT scans in eating disorder patients and controls. Comprehensive Psychiatry, 26, 136-147.
44. Levitan, R.D., Kaplan, A.S., Joffe, R.T., Levitt, A.J. & Brown, G.M. (1997) Hormonal and subjective responses to intravenous meta-Chlorphenylpiperazine in bulimia nervosa. Archives of General Psychiatry, 54, 521-527.
45. Lydiard, R.B., Brandy, K.T., O'Neil, P.M., Schlesier-Carter, B., Hamilton, S., Rogers, Q.&Ballenger, J.C. (1988) Precursor amino acid concentrations in normal weight bulimics and normal controls. Progress in Neuropsychopharmacology and Biological Psychiatry, 12, 893-898.
46. Marazziti, D., Macchi, E., Rotondo, A., Placidi, G.F. & Cassano, G.B. (1988) Involvement of the serotonin system in bulimia. Life Sciences, 43, 2123-2126.
47. McBride, P.A., Anderson, G.M., Khait, V.D., Sunday, S.R. & Halmi, K.A. (1991) Serotonergic responsivity in eating disorders. Psychopharmacology Bulletin, 27, 365-372.
48. Monteleone, P., Brambilla, F., Bortolotti, F., Ferraro, C. & Maj, M. (1998a) Plasma prolactin response to d-fenfluramine is blunted in bulimic patients with frequent binge episodes. Psychological Medicine, 28, 975-983.
49. Monteleone, P., Brambilla, F., Bortolotti, F. & Maj, M. (2000) Serotonergic dysfunction across the eating disorders: relationship to eating behaviour, nutritional status and general psychopathology. Psychological Medicine, 30, 1099-1110.
50. Monteleone, P., Brambilla, F., Bortolotti, F., La Rocca, A. & Maj, M. (1998b) Prolactin response to d-fenfluramine is blunted in people with anorexia nervosa. British Journal of Psychiatry, 172, 438-442.
51. Nozoe, S., Naruo, T., Nakabeppu, Y., Soejima, Y., Nakajo, M. & Tanaka, H. (1993) Changes in cerebral blood flow in patients with anorexia nervosa detected through single photon emission tomography imaging. Biological Psychiatry, 34, 578-580.
52. O'Dwyer, A.M., Lucey, J.V. & Russell, G.M.F. (1996) Serotonin activity in anorexia nervosa after long-term weight restoration: response to d-fenfluramine challenge. Psychological Medicine, 26, 353-359.
53. Okamoto, Y., Okamoto, Y., Kagaya, A., Horiguchi, J. & Yamawaki, S. (1999) The relationship of the platelet 5-HT-induced calcium response to clinical symptoms in eating disorders. Psychopharmacology, 142, 289-294.
54. Okamoto, Y., Okamoto, Y., Kagaya, A., Tamiya, S., Fujita, Y., Tohoda, Y., Motohashi, N. & Yamawaki, S. (1995) Serotonin-induced platelet calcium mobilization is enhanced in bulimia nervosa but not in anorexia nervosa. Biological Psychiatry, 38, 274-276.
55. Oldman, A., Walsh, A., Salkovskis, P., Fairburn, C.G. & Cowen, P.J. (1995) Biochemical and behavioural effects of acute tryptophan depletion in abstinent bulimic subjects: a pilot study. Psychological Medicine, 25, 995-1001.
56. Otto, B., Kuntz, U., Fruehauf, E., Wawarta, R., Folwaczny, C., Riepl, R.L., Heiman, M.L., Lehnert, P., Fichter,M. & Tschop, M. (2001) Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology, 145, 5-9.
57. Roser, W., Bubl, R., Buergin, D., Seelig, J., Radue, E.W. & Rost, B. (1999) Metabolic changes in the brain of patients with anorexia and bulimia nervosa as detected by proton magnetic resonance spectroscopy. International Journal of Eating Disorders, 26, 119-139.
58. Smith, K.A., Fairburn, C.G. & Cowen, P.J. (1999) Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Archives of General Psychiatry, 56, 171-176.
59. Steiger, H., Gauvin, L., Israel, M., Koerner, N., Ng Ying Kin N.M.K., Paris, J. & Young, S.N. (2001b) Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa. Archives of General Psychiatry, 58, 837-843.
60. Steiger, H., Koerner, N., Engelberg, M.J., Israel, M., Ng Ying Kin N.M.K. & Young, S.N. (2001a) Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Research, 103, 15-26.
61. Steiger, H., Young, S.N., Ng Ying Kin N.M.K., Koerner, N., Israel, M., Lageix, P. & Paris, J. (2001c) Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychological Medicine, 31, 85-95.
62. Swayze, V.W. (1997) Brain imaging and eating disorders. Eating Disorders Review, 8, 1-4.
63. Swayze, V.W., Nadersen, A., Arndt, S., Rajarethinam, R., Fleming, F., Sato, Y. & Andreasen, N.C. (1996) Reversibility of brain tissue loss in anorexia nervosa assessed with a computerised Talairach 3-D proportional grid. Psychological Medicine, 26, 381-390.
64. 123Beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biological Psychiatry, 49, 326-332.
65. Ward, A., Brown, N., Lightman, S., Campbell, I.C. & Treasure, J. (1998) Neuroendocrine, appetitive and behavioural responses to d-fenfluramine in women recovered from anorexia nervosa. British Journal of Psychiatry, 172, 351-358.
66. Weizman, R., Carmi, M., Tyano, S., Apter, A. & Rehavi, M. (1986) High affinity 3H-imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sciences, 38, 1235-1242.
67. Weltzin, T.E., Fernstrom, J.D., McConaha, C.& Kaye, W.H. (1994) Acute tryptophan depletion in bulima: effects on large neutral amino acids. Biological Psychiatry, 35, 388-397.
68. Weltzin, T.E., Fernstrom, M.H., Fernstrom, J.D., Neuberger, S.K. & Kaye, W.H. (1995) Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. American Journal of Psychiatry, 152, 1668-1671.
69. Wolfe, B.E., Metzger, E.D., Levine, J.M., Finkelstein, D.M., Cooper, T.B. & Jimerson, D.C. (2000) Serotonin function following remission from bulimia nervosa. Neuropsychopharmacology, 22, 257-263.
70. Wood, A. (1993) Pharmacotherapy of bulimia nervosa-experience with fluoxetine. International Clinical Psychopharmacology, 8, 295-299.
71. Wu, J.C., Hagman, J., Buchsbaum, M.S., Blinder, B., Derfler, M., Tai, W.Y., Hazlett, E. & Sicotte, N. (1990) Greater left cerebral hemispheric metabolism in bulimia assessed by positron emission tomography. American Journal of Psychiatry, 147, 309-312.
72. Zemishlany, Z., Modai, A., Apter, A., Jerushalmy, Z., Samuel, E.&Tyano, S. (1987) Serotonin (5-HT) uptake by blood platelets in anorexia nervosa. Acta Psychiatrica Scandinavica, 75, 127-130.